BARAT STEPHEN enters HTG MOLECULAR DIAGNOSTICS, INC with 1.36K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 2/10/2023ACC: 0001209191-23-008420
Officer· Senior VP of Therapeutics
Since Feb 2023
1.36K
Baseline shares
100% direct
1.36K
Direct ownership
1 position
6.25K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned1.36K
Total
1.36K direct1.36K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.36K | Direct |
| Total | 1.36K | 1.36K direct |
Derivative Holdings2
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
2.08K
Shares owned
N/A
Exercise price
11.28
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
4.17K
Shares owned
N/A
Exercise price
62.41
Expiration
—
Exercise window
—
Total
Underlying
6.25K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock | 11.28 | — | — | 2.08K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 62.41 | — | — | 4.17K | N/A |
| Total | 6.25K | 0.00 | ||||